Dr. Andrew A. Pieper, MD, PhD

Expert Publications

• Poly (ADP-ribose) polymerase, nitric oxide and cell death.
• Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat.
• Drug treatment of depression in HIV-positive patients : safety considerations.
• The NPAS3 gene--emerging evidence for a role in psychiatric illness.
• Acid promoted cinnamyl ion mobility within peptide derived macrocycles.
• Development of proneurogenic, neuroprotective small molecules.
• Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.
• Forebrain elimination of cacna1c mediates anxiety-like behavior in mice.
• Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.
• Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.
• Selective genetic deletion of cacna1c in the mouse prefrontal cortex.
• Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice.
• Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury.
• Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties.

Media Releases

Get to know Psychiatrist Dr. Andrew A. Pieper, who serves patients in Cleveland, Ohio.

Dr. Pieper is a board-certified psychiatrist and neuroscientist in the Department of Psychiatry at Case Western Reserve University and University Hospitals Cleveland Medical Center, where he serves as Professor and Morley Mather Chair in Neuropsychiatry. He also serves as Psychiatrist at the Louis Stokes Cleveland VA Medical Center (VAMC), and as Investigator in the University Hospitals Harrington Discovery Institute, where he is the Director of the Neurotherapeutics Center. 

Dr. Pieper is devoted to patient care and basic science research applied to disease, most keenly focused on neurodegeneration. Clinically, he maintains an active Adult Psychiatry Outpatient Clinic at the VAMC. His goal is to understand and investigate human disorders in order to foster development of new neuroprotective strategies to support brain health. Dr. Pieper has received numerous honors, including the Staglin Family Rising Star Research Award from the International Mental Health Research Organization and elected membership to the American Society for Clinical Investigation.

After graduating from Earlham College in Richmond, Indiana, Dr. Pieper earned his MD and PhD (Neuroscience) degrees from Johns Hopkins University School of Medicine. He also conducted his internship and residency at Johns Hopkins Hospital, and postdoctoral fellowship in Biochemistry at University of Texas Southwestern Medical Center (UTSWMC). He joined the faculty at UTSWMC from 2006 until 2012, after which he moved to the University of Iowa Carver College of Medicine where he became Director of Translational Neuroscience. In 2018, Dr. Pieper moved to Cleveland to join University Hospitals Cleveland Medical Center, Case Western Reserve University, and the Louis Stokes VAMC.

Licensed to practice medicine in Ohio, he is board-certified in psychiatry by the American Board of Psychiatry and Neurology, a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology.

Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of mental disorders. These include various maladaptations related to mood, behavior, cognition, and perceptions. Psychiatrists evaluate, diagnose, and treat patients with mental, emotional, and behavioral disorders. They conduct thorough psychiatric evaluations, develop treatment plans, prescribe medication, and evaluate treatment results.

Recommended Articles

• Is Multiple Sclerosis Genetic?

  Multiple Sclerosis is a complex disease that can be caused by several factors; genetic structure is one of them. Several genes are thought to play a role in the development of MS. If any of a close relative, such as a sibling or a parent, has this disease, your chance of developing MS is slightly...

• ADHD in Children

  ADHD usually develops during childhood, and there have been no cases of the condition occurring in adults who didn’t have it in their childhood. As a result, ADHD is best diagnosed and managed during childhood and for the rest of the life. When it comes to spotting ADHD symptoms in children, the...

• Pristiq vs. Effexor

  Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...

• What Is the Difference Between Depression and Anxiety?

  Understanding the difference between depression and anxiety is not an easy task, as mental health conditions are far more complicated. The most common mental illnesses are depression, anxiety, and substance use disorder. It is common for these three types of mental illnesses to occur in combination....

• How Does Saphris Work?

  Mechanism of ActionSaphris is an atypical antipsychotic used for the treatment of schizophrenia and bipolar disorder in both adults and children ages 10 years old and above. The drug's exact mechanism of action is still unknown. However, it is believed that like other antipsychotics, it interferes...

• What Is Euthymia?

  IntroductionA person is often regarded as when in the longitudinal course of mood disturbances, the threshold of a disorder is not met. People with bipolar disorder may spend most of their time in the state of mania, depression, or in a mixed state, while the rest are in euthymia. Certain...